Literature DB >> 6768226

Methodology for the control of intracranial pressure with hypertonic mannitol.

H E James.   

Abstract

The response to intravenous bolus administrations and continuous infusions of hypertonic mannitol to control elevated (greater than 25 torr) intracranial pressure (ICP) is presented. Sixty patients received 120 bolus infusions of mannitol (0.18-2.5 g/kg/dose) with a prompt peak reduction at 44 minutes (range 18 to 120 minutes). There was no relationship between dosage and rapidity of peak response. All administrations of 1.0g/kg/dose, or higher, consistently reduced ICP 10% or more from control values, but dosages below 1 gm/kg/dose did not always reduce ICP. Return to control ICP following mannitol was unpredictable, and was related to the initial ICP and the volume of fluid replacement. A continuous infusion of mannitol was administered to maintain ICP below 25 torr in 18 patients. This infusion ranged from 6 to 100 hours (X 28.8+/-28.9 hours) and required a total dosage of 2-20 mg/kg, and was successful in 16 of the 18 patients. Emphasis is placed on close observation of the patient's serum osmolality and electrolytes during therapy, as well as quality and magnitude of replacement. No set rules are given for control of ICP, but a guideline is made to meet the individual patient's requirements.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768226     DOI: 10.1007/bf01406742

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  35 in total

1.  THE EFFECTS OF MANNITOL AND UREA ON CEREBRAL HEMODYNAMICS AND CEREBROSPINAL FLUID PRESSURE.

Authors:  B GOLUBOFF; H A SHENKIN; H HAFT
Journal:  Neurology       Date:  1964-10       Impact factor: 9.910

2.  EFFECTS OF INFUSION OF HYPERTONIC MANNITOL ON ELECTROLYTE BALANCE AND ON OSMOLARITY OF SERUM AND CEREBROSPINAL FLUID.

Authors:  B L WISE
Journal:  J Neurosurg       Date:  1963-11       Impact factor: 5.115

3.  HYPERTONIC UREA IN EXPERIMENTAL CEREBRAL EDEMA.

Authors:  R A CLASEN; P M COOKE; S PANDOLFI; G CARNECKI; G BRYAR
Journal:  Arch Neurol       Date:  1965-04

4.  THE REBOUND PHENOMENON AND HYPERTONIC SOLUTIONS.

Authors:  M JAVID; D GILBOE; T CESARIO
Journal:  J Neurosurg       Date:  1964-12       Impact factor: 5.115

5.  DEHYDRATION AND REHYDRATION OF THE BRAIN WITH HYPERTONIC UREA AND MANNITOL.

Authors:  J D MCQUEEN; L D JEANES
Journal:  J Neurosurg       Date:  1964-02       Impact factor: 5.115

6.  Cytotoxic edema produced by 6-aminonicotinamide and its response to therapy.

Authors:  H E James; D A Bruce; F Welsh
Journal:  Neurosurgery       Date:  1978 Sep-Oct       Impact factor: 4.654

7.  Effects of single, repeated and massive mannitol infusion in the dog: structural and functional changes in kidney and brain.

Authors:  F P Stuart; E Torres; R Fletcher; D Crocker; F D Moore
Journal:  Ann Surg       Date:  1970-08       Impact factor: 12.969

8.  Effects of intravenously administered hypertonic urea solution.

Authors:  J W Beks; A Groen; T Huizinga; K H Noordhoek; J M Smit; W G Walter
Journal:  Acta Neurochir (Wien)       Date:  1965       Impact factor: 2.216

9.  The influence of urea and mannitol on increased intraventricular pressure in cold-induced cerebral oedema.

Authors:  J W Beks; C A ter Weeme
Journal:  Acta Neurochir (Wien)       Date:  1967       Impact factor: 2.216

10.  Restricted fluid intake. Rational management of the neurosurgical patient.

Authors:  H A Shenkin; H S Bezier; W F Bouzarth
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

View more
  21 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 2.  New concepts in treatment of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Anesthesiol Clin       Date:  2009-06

3.  Therapeutic Hypothermia Reduces Intracranial Pressure and Partial Brain Oxygen Tension in Patients with Severe Traumatic Brain Injury: Preliminary Data from the Eurotherm3235 Trial.

Authors:  Liam M C Flynn; Jonathan Rhodes; Peter J D Andrews
Journal:  Ther Hypothermia Temp Manag       Date:  2015-05-19       Impact factor: 1.286

4.  Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent.

Authors:  Lei Feng; Beverly A Kienitz; Carolyn Matsumoto; Jeffrey Bruce; Michael Sisti; Hoang Duong; John Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

5.  Osmolar therapy in pediatric traumatic brain injury.

Authors:  Tellen D Bennett; Kimberly D Statler; E Kent Korgenski; Susan L Bratton
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

6.  Effect of mannitol on cerebral blood volume in patients with head injury.

Authors:  Michael N Diringer; Michael T Scalfani; Allyson R Zazulia; Tom O Videen; Rajat Dhar; William J Powers
Journal:  Neurosurgery       Date:  2012-05       Impact factor: 4.654

Review 7.  Neuroprotective measures in children with traumatic brain injury.

Authors:  Shruti Agrawal; Ricardo Garcia Branco
Journal:  World J Crit Care Med       Date:  2016-02-04

Review 8.  The role for osmotic agents in children with acute encephalopathies: a systematic review.

Authors:  Samson Gwer; Hellen Gatakaa; Leah Mwai; Richard Idro; Charles R Newton
Journal:  BMC Pediatr       Date:  2010-04-17       Impact factor: 2.125

Review 9.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

10.  Acute dimethyl sulphoxide therapy in experimental brain oedema, effect of dose and concentration on brain water and electrolyte content.

Authors:  J Tsuruda; H E James; R Werner; P E Camp; G Rasmussen
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.